/any–

Session

Pre-market covers 04:00–09:30 ET, intraday 09:30–16:00, after-hours 16:00–20:00.

Float market cap ($B)

to

The quick buttons above just fill these in. Type your own numbers and they release.

Event type

QURE

uniQure N.V.

September 23, 2026 · after-hours

Rarity
1.96
Peak move
−13.81%
Float cap
$2.4B

uniQure N.V. is a gene therapy company developing single treatments with potentially curative results for patients with rare and other devastating diseases. It is advancing clinical candidates for Huntington’s disease, refractory mesial temporal lobe epilepsy, Fabry disease, and amyotrophic lateral sclerosis caused by SOD1 mutations. These investigational therapies are intended for patients with serious, rare conditions and are not yet approved for commercial sale.

Where do you see this going?

no votes yet

Voting closed at 4:00 PM ET.

What we found

1 event · 0 from SEC or newswire · 0 timed with the move
  • analyst_rating

    Weiss Ratings upgraded its outlook on uniQure (NASDAQ: QURE) on September 21, 2026, setting a "Sell (D-)" rating on the shares.